Evidence map›Paper›PMID 38313289›Full record

ArticlebioRxiv : the preprint server for biology2024

Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection.

Sung Hee Ko, Pierce Radecki, Frida Belinky, Jinal N Bhiman, Susan Meiring, Jackie Kleynhans, Daniel Amoako, Vanessa Guerra Canedo, Margaret Lucas, Dikeledi Kekana and 11 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 3 countries.

Sung Hee KoVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Pierce RadeckiVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Frida BelinkyVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Jinal N BhimanNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Susan MeiringNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Jackie KleynhansNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-7081-6273
Daniel AmoakoNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Vanessa Guerra CanedoVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Margaret LucasVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Dikeledi KekanaNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Neil MartinsonPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Limakatso LebinaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Josie EverattNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Stefano TempiaNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Tatsiana BylundVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Reda RawiVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Nicole WolterNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Anne von GottbergNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
Cheryl CohenNational Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0003-0376-2302
Eli A BoritzVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-4633-4594
National Health Laboratory Service · ZANational Institutes of Health · USJohns Hopkins University · USUniversity of the Witwatersrand · ZA

Funding

Wellcome Trust
6 · The paper itself

Abstract

Previous studies have linked the evolution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic variants to persistent infections in people with immunocompromising conditions

Identifiers

PMID38313289
PMCPMC10836083
OpenAlexW4390689504

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.